Cost-effectiveness of Chloride-liberal versus Chloriderestrictive Intravenous Fluids among Patients Hospitalized in the United States.

Perrault, Louise; Makhija, Dilip; Beer, Idal; Laplante, Suzanne; Iannazzo, Sergio; Raghunathan, Karthik

Perrault, Louise; Makhija, Dilip; Beer, Idal; Laplante, Suzanne; Iannazzo, Sergio; Raghunathan, Karthik.

Afiliação

Perrault L; International Market Access Consulting, Inc., Zug, Switzerland.
Makhija D; Baxter Healthcare Corporation, Deerfield, IL, USA.
Beer I; Baxter Healthcare Corporation, Deerfield, IL, USA.
Laplante S; Baxter Healthcare Corporation, Deerfield, IL, USA.
Iannazzo S; SIHS Health Economics Consulting, Torino, Italy.
Raghunathan K; Duke University Medical Center, Division of Veterans Affairs, Durham, NC, USA.

J Health Econ Outcomes Res ; 4(1): 90-102, 2016.

Article em En | MEDLINE | ID: mdl-34414248

Palavras-chave

cost-effectiveness analysis; crystalloids; electrolytes; intravenous fluid therapy; intravenous rehydration solutions; plasma substitutes

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspecto: Patient_preference Idioma: En Revista: J Health Econ Outcomes Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suíça País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google